Ledger.Open graph →
SEC Form D · filed August 20, 2015

Chase Pharmaceuticals Corp

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WASHINGTON, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Karoly N. Nikolich · Washington, Washington, D.C.DirectorStephen N. Cunningham · Washington, Washington, D.C.DirectorJohn M. Reher · Washington, Washington, D.C.DirectorVikram M. Sudarsan · Washington, Washington, D.C.DirectorKathleen N. Clarence-Smith · Washington, Washington, D.C.ExecThomas N. Chase · Washington, Washington, D.C.Exec · DirectorN. G. Parekh · Washington, Washington, D.C.DirectorRaphael M. Wisniewski · Washington, Washington, D.C.DirectorJohn M. Siebert · Kailua Kona, HIExecAdamas Capital Management, LP · Boston, MAExec · DirectorPatty White · COLUMBUS, OHDirectorPeter Anadranistakis · Scottsdale, AZDirectorJodan Ledford · Chicago, ILExecRobert Moore · Chicago, ILDirectorJoseph C. Robillard · Berkeley Heights, NJDirectorTimothy C. Klag · Berkeley Heights, NJExec · DirectorJoseph C. Robillard · Berkeley Heights, NJDirectorMatthew Shaxted · Chicago, ILExecMichael Wilde · Chicago, ILExec · DirectorMichela Wilde · Chicago, ILDirectorLisa A. Arington-Glesinger · Cottage Grove, WIExecStephen N. Cunningham · Washington, Washington, D.C.DirectorN. G. Parekh · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗